FDA Drug Application (203435) for LERIBANE by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number203435
Product Number001
FormTABLET;ORAL
Dosage0.005MG;1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLERIBANE
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by NOVAST LABS LTD